Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe.

Hunt M, Bradley P, Lapierre SG, Heys S, Thomsit M, Hall MB, Malone KM, Wintringer P, Walker TM, Cirillo DM, Comas I, Farhat MR, Fowler P, Gardy J, Ismail N, Kohl TA, Mathys V, Merker M, Niemann S, Omar SV, Sintchenko V, Smith G, van Soolingen D, Supply P, Tahseen S, Wilcox M, Arandjelovic I, Peto TEA, Crook DW, Iqbal Z.

Wellcome Open Res. 2019 Dec 2;4:191. doi: 10.12688/wellcomeopenres.15603.1. eCollection 2019.

2.

Multifocal and multicentric breast cancer, is it time to think again?

Masannat YA, Agrawal A, Maraqa L, Fuller M, Down SK, Tang S, Pang D, Kontos M, Romics L, Heys SD.

Ann R Coll Surg Engl. 2020 Jan;102(1):62-66. doi: 10.1308/rcsann.2019.0109. Epub 2019 Sep 6. Review.

PMID:
31891668
3.

Anticancer effects of n-3 EPA and DHA and their endocannabinoid derivatives on breast cancer cell growth and invasion.

Brown I, Lee J, Sneddon AA, Cascio MG, Pertwee RG, Wahle KWJ, Rotondo D, Heys SD.

Prostaglandins Leukot Essent Fatty Acids. 2019 Oct 16:102024. doi: 10.1016/j.plefa.2019.102024. [Epub ahead of print]

PMID:
31679810
4.

Optimal Phased-Array Signal Combination For Polyunsaturated Fatty Acids Measurement In Breast Cancer Using Multiple Quantum Coherence MR Spectroscopy At 3T.

Mallikourti V, Cheung SM, Gagliardi T, Masannat Y, Heys SD, He J.

Sci Rep. 2019 Jun 25;9(1):9259. doi: 10.1038/s41598-019-45710-1.

5.

A self-help diet and physical activity intervention with dietetic support for weight management in men treated for prostate cancer: pilot study of the Prostate Cancer Weight Management (PRO-MAN) randomised controlled trial.

Mohamad H, Ntessalen M, Craig LCA, Clark J, Fielding S, N'Dow J, Heys SD, McNeill G.

Br J Nutr. 2019 Sep 14;122(5):592-600. doi: 10.1017/S0007114519001090.

PMID:
31177994
6.

Toward an Ethically Founded Framework for the Use of Mobile Phone Call Detail Records in Health Research.

Jones KH, Daniels H, Heys S, Ford DV.

JMIR Mhealth Uhealth. 2019 Mar 22;7(3):e11969. doi: 10.2196/11969.

7.

Pilot randomised controlled trial of Weight Watchers® referral with or without dietitian-led group support for weight loss in women treated for breast cancer: the BRIGHT (BReast cancer weIGHT loss) trial.

Newlands RSN, Ntessalen M, Clark J, Fielding S, Hoddinott P, Heys SD, McNeill G, Craig LCA.

Pilot Feasibility Stud. 2019 Feb 13;5:24. doi: 10.1186/s40814-019-0405-x. eCollection 2019.

8.

Public Views on Using Mobile Phone Call Detail Records in Health Research: Qualitative Study.

Jones KH, Daniels H, Heys S, Ford DV.

JMIR Mhealth Uhealth. 2019 Jan 16;7(1):e11730. doi: 10.2196/11730.

9.

Challenges and Potential Opportunities of Mobile Phone Call Detail Records in Health Research: Review.

Jones KH, Daniels H, Heys S, Ford DV.

JMIR Mhealth Uhealth. 2018 Jul 19;6(7):e161. doi: 10.2196/mhealth.9974. Review.

10.

Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ.

Masannat YA, Husain E, Roylance R, Heys SD, Carder PJ, Ali H, Maurice Y, Pinder SE, Sawyer E, Shaaban AM.

Breast. 2018 Apr;38:120-124. doi: 10.1016/j.breast.2017.12.011. Epub 2018 Jan 5.

PMID:
29310036
11.

Corrigendum: Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, Earle S, Pankhurst LJ, Anson L, de Cesare M, Piazza P, Votintseva AA, Golubchik T, Wilson DJ, Wyllie DH, Diel R, Niemann S, Feuerriegel S, Kohl TA, Ismail N, Omar SV, Smith EG, Buck D, McVean G, Walker AS, Peto TE, Crook DW, Iqbal Z.

Nat Commun. 2016 Apr 20;7:11465. doi: 10.1038/ncomms11465. No abstract available.

12.

Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, Earle S, Pankhurst LJ, Anson L, de Cesare M, Piazza P, Votintseva AA, Golubchik T, Wilson DJ, Wyllie DH, Diel R, Niemann S, Feuerriegel S, Kohl TA, Ismail N, Omar SV, Smith EG, Buck D, McVean G, Walker AS, Peto TE, Crook DW, Iqbal Z.

Nat Commun. 2015 Dec 21;6:10063. doi: 10.1038/ncomms10063. Erratum in: Nat Commun. 2016;7:11465.

13.

2. Newly qualified midwives.

Taylor K, Heys S, Evans J.

Pract Midwife. 2015 Nov;18(10):46-51.

PMID:
26669054
14.

Older Patients Are Immunocompromised by Cytokine Depletion and Loss of Innate Immune Function After HIP Fracture Surgery.

Sutherland AG, Cook A, Miller C, Duncan L, Yuecel R, Heys SD, Hutchison JD, Liversidge J.

Geriatr Orthop Surg Rehabil. 2015 Dec;6(4):295-302. doi: 10.1177/2151458515605564.

15.

Breast cancer risk and imprinting methylation in blood.

Harrison K, Hoad G, Scott P, Simpson L, Horgan GW, Smyth E, Heys SD, Haggarty P.

Clin Epigenetics. 2015 Sep 4;7:92. doi: 10.1186/s13148-015-0125-x. eCollection 2015.

16.

Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.

Yang B, Cao L, Liu J, Xu Y, Milne G, Chan W, Heys SD, McCaig CD, Pu J.

Cancer. 2015 May 15;121(10):1570-80. doi: 10.1002/cncr.29235. Epub 2015 Jan 20.

17.

The effect of dietary and exercise interventions on body weight in prostate cancer patients: a systematic review.

Mohamad H, McNeill G, Haseen F, N'Dow J, Craig LC, Heys SD.

Nutr Cancer. 2015;67(1):43-60. doi: 10.1080/01635581.2015.976313. Epub 2014 Nov 25. Review.

PMID:
25425328
18.

Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study.

Bruce J, Thornton AJ, Powell R, Johnston M, Wells M, Heys SD, Thompson AM, Cairns Smith W, Chambers WA, Scott NW; Recovery Study Group.

Pain. 2014 Feb;155(2):232-43. doi: 10.1016/j.pain.2013.09.028. Epub 2013 Oct 4.

PMID:
24099954
19.

Regulation of fatty acid synthase (FAS) and apoptosis in estrogen-receptor positive and negative breast cancer cells by conjugated linoleic acids.

Song HJ, Sneddon AA, Heys SD, Wahle KW.

Prostaglandins Leukot Essent Fatty Acids. 2012 Dec;87(6):197-203. doi: 10.1016/j.plefa.2012.09.002. Epub 2012 Nov 8.

PMID:
23142364
20.

Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.

Brown I, Cascio MG, Rotondo D, Pertwee RG, Heys SD, Wahle KW.

Prog Lipid Res. 2013 Jan;52(1):80-109. doi: 10.1016/j.plipres.2012.10.001. Epub 2012 Oct 26. Review.

PMID:
23103355
21.

Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer.

Heys SD, Stewart KN, McKenzie EJ, Miller ID, Wong SY, Sellar G, Rees AJ.

Breast Cancer Res Treat. 2012 Sep;135(2):539-48. doi: 10.1007/s10549-012-2190-6. Epub 2012 Aug 11.

PMID:
22886449
22.

Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer.

Bruce J, Thornton AJ, Scott NW, Marfizo S, Powell R, Johnston M, Wells M, Heys SD, Thompson AM.

Br J Cancer. 2012 Sep 4;107(6):937-46. doi: 10.1038/bjc.2012.341. Epub 2012 Jul 31.

23.

The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy.

Di Giovanni P, Ahearn TS, Semple SI, Lovell LM, Miller I, Gilbert FJ, Redpath TW, Heys SD, Staff RT.

Breast Cancer Res Treat. 2012 Jun;133(3):1199-206. doi: 10.1007/s10549-012-2014-8. Epub 2012 Mar 24.

PMID:
22447179
24.

Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

McLay JS, Stewart D, George J, Rore C, Heys SD.

Eur J Clin Pharmacol. 2012 May;68(5):811-9. doi: 10.1007/s00228-011-1181-6. Epub 2011 Dec 14.

PMID:
22166933
25.

Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines.

Brown I, Wahle KW, Cascio MG, Smoum-Jaouni R, Mechoulam R, Pertwee RG, Heys SD.

Prostaglandins Leukot Essent Fatty Acids. 2011 Dec;85(6):305-10. doi: 10.1016/j.plefa.2011.09.007. Epub 2011 Oct 12.

PMID:
21995886
26.

The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.

Robertson C, Arcot Ragupathy SK, Boachie C, Dixon JM, Fraser C, Hernández R, Heys S, Jack W, Kerr GR, Lawrence G, MacLennan G, Maxwell A, McGregor J, Mowatt G, Pinder S, Ternent L, Thomas RE, Vale L, Wilson R, Zhu S, Gilbert FJ.

Health Technol Assess. 2011 Sep;15(34):v-vi, 1-322. doi: 10.3310/hta15340. Review.

27.

Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review.

Robertson C, Ragupathy SK, Boachie C, Fraser C, Heys SD, Maclennan G, Mowatt G, Thomas RE, Gilbert FJ; Mammographic Surveillance Health Technology Assessment Group.

Eur Radiol. 2011 Dec;21(12):2484-91. doi: 10.1007/s00330-011-2226-z. Epub 2011 Aug 11. Review.

28.

Moving inwards, moving outwards, moving upwards: the role of spirituality during the early stages of breast cancer.

Swinton J, Bain V, Ingram S, Heys SD.

Eur J Cancer Care (Engl). 2011 Sep;20(5):640-52. doi: 10.1111/j.1365-2354.2011.01260.x. Epub 2011 Jul 19.

PMID:
21771127
29.

SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy.

Collie-Duguid ES, Sweeney K, Stewart KN, Miller ID, Smyth E, Heys SD.

Breast Cancer Res Treat. 2012 Apr;132(3):807-18. doi: 10.1007/s10549-011-1625-9. Epub 2011 Jun 22.

PMID:
21695460
30.

Impaired expression of glutathione peroxidase-4 gene in peripheral blood mononuclear cells: a biomarker of increased breast cancer risk.

Bermano G, Smyth E, Goua M, Heys SD, Wahle KW.

Cancer Biomark. 2010;7(1):39-46. doi: 10.3233/CBM-2010-0146.

PMID:
21045263
31.

Profiling the expression of cytochrome P450 in breast cancer.

Murray GI, Patimalla S, Stewart KN, Miller ID, Heys SD.

Histopathology. 2010 Aug;57(2):202-11. doi: 10.1111/j.1365-2559.2010.03606.x.

PMID:
20716162
32.

Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines.

Brown I, Cascio MG, Wahle KW, Smoum R, Mechoulam R, Ross RA, Pertwee RG, Heys SD.

Carcinogenesis. 2010 Sep;31(9):1584-91. doi: 10.1093/carcin/bgq151. Epub 2010 Jul 25.

33.

Using live theatre in teaching about domestic abuse.

Ross S, Heys S, Galley H.

Med Educ. 2010 May;44(5):503-4. doi: 10.1111/j.1365-2923.2010.03646.x. Epub 2010 Mar 30. No abstract available.

PMID:
20374461
34.

Enhancing cytotoxic therapies for breast and prostate cancers with polyunsaturated fatty acids.

Shaikh IA, Brown I, Wahle KW, Heys SD.

Nutr Cancer. 2010;62(3):284-96. doi: 10.1080/01635580903407189. Review.

PMID:
20358465
35.

The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature.

Peare R, Staff RT, Heys SD.

Breast Cancer Res Treat. 2010 Aug;123(1):281-90. doi: 10.1007/s10549-010-0771-9. Epub 2010 Feb 7. Review.

PMID:
20140703
36.

Plant phenolics in the prevention and treatment of cancer.

Wahle KW, Brown I, Rotondo D, Heys SD.

Adv Exp Med Biol. 2010;698:36-51. Review.

PMID:
21520702
37.

Genetic polymorphism in ornithine decarboxylase and risk of breast cancer.

Brown I, Halliday S, Greig H, Heys SD, Wallace HM, Schofield AC.

Fam Cancer. 2009;8(4):307-11. doi: 10.1007/s10689-009-9237-9. Epub 2009 Feb 19.

PMID:
19225907
38.

Inhibition of gastric cancer cell growth by arginine: molecular mechanisms of action.

Nanthakumaran S, Brown I, Heys SD, Schofield AC.

Clin Nutr. 2009 Feb;28(1):65-70. doi: 10.1016/j.clnu.2008.10.007. Epub 2008 Nov 25.

PMID:
19036482
39.

Student views on the introduction of anatomy teaching packages into clinical attachments.

Dawson AG, Bruce SA, Heys SD, Stewart IJ.

Clin Anat. 2009 Mar;22(2):267-72. doi: 10.1002/ca.20732.

PMID:
19031397
40.

Immuno-modulatory effects of relaxation training and guided imagery in women with locally advanced breast cancer undergoing multimodality therapy: a randomised controlled trial.

Eremin O, Walker MB, Simpson E, Heys SD, Ah-See AK, Hutcheon AW, Ogston KN, Sarkar TK, Segar A, Walker LG.

Breast. 2009 Feb;18(1):17-25. doi: 10.1016/j.breast.2008.09.002. Epub 2008 Nov 12.

41.

Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.

Shaikh IA, Brown I, Schofield AC, Wahle KW, Heys SD.

Prostate. 2008 Nov 1;68(15):1635-46. doi: 10.1002/pros.20830.

PMID:
18668525
42.

Atherosclerosis: cell biology and lipoproteins.

Wahle KW, Heys SD.

Curr Opin Lipidol. 2008 Aug;19(4):435-7. doi: 10.1097/MOL.0b013e328306f0cc. No abstract available.

PMID:
18607194
43.

Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.

Reid DM, Doughty J, Eastell R, Heys SD, Howell A, McCloskey EV, Powles T, Selby P, Coleman RE.

Cancer Treat Rev. 2008;34 Suppl 1:S3-18. doi: 10.1016/j.ctrv.2008.03.007. Epub 2008 Jun 2.

PMID:
18515009
44.

Potentiation of the anti-tumour effect of docetaxel by conjugated linoleic acids (CLAs) in breast cancer cells in vitro.

Fite A, Goua M, Wahle KW, Schofield AC, Hutcheon AW, Heys SD.

Prostaglandins Leukot Essent Fatty Acids. 2007 Aug;77(2):87-96. Epub 2007 Sep 27.

PMID:
17900885
45.

Ion trap mass spectrometry on a comet nucleus: the Ptolemy instrument and the Rosetta space mission.

Todd JF, Barber SJ, Wright IP, Morgan GH, Morse AD, Sheridan S, Leese MR, Maynard J, Evans ST, Pillinger CT, Drummond DL, Heys SC, Huq SE, Kent BJ, Sawyer EC, Whalley MS, Waltham NR.

J Mass Spectrom. 2007 Jan;42(1):1-10.

PMID:
17154436
46.

Good for them or good for us? The role of academic guidance interviews.

Denison AR, Currie AE, Laing MR, Heys SD.

Med Educ. 2006 Dec;40(12):1188-91.

PMID:
17118112
47.

Monitoring primary breast cancer throughout chemotherapy using FDG-PET.

McDermott GM, Welch A, Staff RT, Gilbert FJ, Schweiger L, Semple SI, Smith TA, Hutcheon AW, Miller ID, Smith IC, Heys SD.

Breast Cancer Res Treat. 2007 Mar;102(1):75-84. Epub 2006 Aug 9.

PMID:
16897427
48.

Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration.

Semple SI, Staff RT, Heys SD, Redpath TW, Welch AE, Ahearn TS, Hutcheon A, Gilbert FJ.

Ann Oncol. 2006 Sep;17(9):1393-8. Epub 2006 Jun 20.

49.

A pilot study with long term follow up of hyperbaric oxygen pretreatment in patients with locally advanced breast cancer undergoing neo-adjuvant chemotherapy.

Heys SD, Smith IC, Ross JA, Gilbert FJ, Brooks J, Semple S, Miller ID, Hutcheon A, Sarkar T, Eremin O.

Undersea Hyperb Med. 2006 Jan-Feb;33(1):33-43.

PMID:
16602255

Supplemental Content

Support Center